Peter Emtage is the founder of Santa Ana Bio. Santa Ana Bio has raised $168M in total funding. Latest round: Series B. Backed by Versant Ventures, GV.
Peter Emtage is the CEO of Santa Ana Bio, a company focused on developing precision medicines for inflammatory diseases. He leads the company's efforts in identifying pathogenic cell types and pathways, and leveraging protein engineering to create antibody-based therapies.
Full founder directory · Investor directory · Company funding database · Fundraising library